The first UK research study into the medical benefits of cannabis on Multiple Scelrosis has shown there is no benefit.
However there were benefits for those at the lower end of the disability scale.
The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study was carried out by researchers from the Peninsula College of Medicine and Dentistry.
It enrolled nearly 500 people with MS from 27 centres around the UK, who were either given capsules containing the active ingredient of cannabis and some given a placebo.
Alison Smith, an MS sufferer took part in the trial:
More top news
A young grey seal found in a farmer's field on Monday is making progress say RSPCA staff. He's thought to have a head injury.
The UK economy, boosted by the inclusion of the sex and drugs industry in the calculations, is now the world's fifth largest, but only just.
Wet and windy weather will spread in from the west, turning to snow in places, especially later over the hills.